Answers are grounded in this paper and cite their sources.
Asymmetric arm swing reduction is a hallmark of early-stage Parkinson’s disease (PD). We evaluated wrist sensor-based arm swing measures during free-living gait as digital progression biomarkers in 623 early-stage PD participants and 50 controls monitored continuously for one year (controls) or two years (PD). Biweekly measures were extracted from detected gait segments without other arm activities using a previously validated signal processing pipeline. Arm swing measures were reduced in PD, reduced on the most affected side, moderately correlated with clinical motor severity, and highly reliable. In unmedicated participants, most affected side measures declined over one year (standardized response means: −0.34 to −0.85) and all but one over two years ( −0.57 to −1.06). The corresponding MDS-UPDRS Part III subscore showed SRMs of −0.26 (95% CI [−0.66, 0.06]) at one year and −0.85 (95% CI [-1.95, -0.24]) at two years. In medicated participants, arm swing increased on the most affected side, which was associated with higher dopaminergic doses and dyskinesia. Overall, free-living arm swing measures are promising progression biomarkers in early, untreated PD.
No takes yet. Share an insight, caveat, or question.
Post et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: